Regentis Biomaterials Ltd. (RGNT:NYSEMKT) closed at $1.23 on November 13, 2026, down 1.60% on the day. The stock trades 92.1% below its 52-week high of $15.50 and 6.0% above its 52-week low of $1.16. Over the past year, it lost 83.6%. Regentis Biomaterials Ltd. is part of the Health Care sector.
In 237 trading sessions since December 5, 2025, RGNT closed higher on 91 days (38%). Its best day was June 15, 2026 (+526.67%) and its worst was June 16, 2026 (-35.11%). The stock moved 10% or more in a single session 26 times. It opened at least 5% above the previous day's high 6 times.
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore the health and enhance quality of life of patients. Our current efforts are focused on orthopedic treatments using our Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue).
Find more stocks like RGNT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.